← All trials
NCT03747042
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 19, 2018
- Primary completion
- Nov 30, 2023
- Completion date
- Nov 30, 2024
- First posted
- —
- Last posted
- —
- Enrollment
- 300
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- The University of Texas, DallasLead sponsor
- The University of Texas, DallasOverall official - principal investigator
- State of TexasCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.